Qalsody™ (tofersen) – New orphan drug approval
April 25, 2023 - The FDA announced the approval of Biogen’s Qalsody (tofersen), for the treatment of amyotrophic lateral sclerosis (ALS) in adults who have a mutation in the superoxide dismutase 1 (SOD1) gene.
Download PDF
